ESR1 and breast carcinoma: Within the group of estrogen receptor + (ER+) tumors is the ER+/pathologic response – (PR–) subtype associated with less favorable outcomes.[6] The etiology of breast cancer has generally been attributed to genetic, reproductive, and hormonal factors.